Lotus Pharmaceutical Co., Ltd.
TWSE:1795.TW
Overview | Financials
Company Name | Lotus Pharmaceutical Co., Ltd. |
Symbol | 1795.TW |
Currency | TWD |
Price | 282 |
Market Cap | 74,784,708,000 |
Dividend Yield | 1.23% |
52-week-range | 210.5 - 347 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Petar Antonov Vazharov |
Website | https://www.lotuspharm.com.tw |
An error occurred while fetching data.
About Lotus Pharmaceutical Co., Ltd.
Lotus Pharmaceutical Co., Ltd. research, develops, manufactures, and sells generic pharmaceutical products in Taiwan, Korea, the United States, and internationally. Its product portfolio focuses on generics in the fields of oncology, cardiology, nephrology, women's health, anti-obesity, and central nervous system disease. The company also sells and markets a portfolio of
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD